Reduction in Toxicity of Doxorubicin by á-Tocopherol Succinate (vitamin E) and Ascorbic Acid (vitamin C) in Human Adenocarcinoma Cells

Authors

Christie Michaud, Brigham Young University
Dr. Byron Murray, Brigham Young University

Keywords

toxicity, doxorubicin, DXR, á-tocopherol succivitamin E, ascorbic acid, vitamin C, human adenocarcinoma cells

College

Life Sciences

Department

Microbiology and Molecular Biology

Abstract

Colorectal cancer is the second leading cause of cancer deaths in the United States and doxorubicin, is one of the more widely chemotherapeutic treatments for this disease. This study investigated the possibility of exposing adenocarcinoma cells to vitamin C/vitamin E (VC/VE) combinations as a means to reduce toxicity associated with doxorubicin (DXR) treatment.

Recommended Citation

Michaud, Christie and Murray, Dr. Byron (2014) "Reduction in Toxicity of Doxorubicin by á-Tocopherol Succinate (vitamin E) and Ascorbic Acid (vitamin C) in Human Adenocarcinoma Cells," Journal of Undergraduate Research: Vol. 2014: Iss. 1, Article 834.
Available at: https://scholarsarchive.byu.edu/jur/vol2014/iss1/834